Skip to content
Research Article Open access CC BY 4.0

Samter’s Triad: Rare or Under-Diagnosed?

Adekunle Olatayo Adeoti, Oluwatoba Ezekiel Osasona, Olatunji Bukola Olaoye, Olufemi O. Desalu

International Journal of Medical and Pharmaceutical Case Reports · pp. 1–5 · Published 25 Feb 2016

10.9734/IJMPCR/2016/24677

Abstract

Samter’s triad is an acquired inflammatory disorder characterized by asthma, nasal polyps and aspirin sensitivity. Aspirin sensitivity is the hallmark of this condition. It is a form of pseudo-allergy, as IgE does not play any significant role in its pathophysiology. There is a paucity of reported cases of Samter’s triad in Africa. Our patient is a 24-year old female who presented with worsening of asthmatic symptoms and naso-ocular complaints after thirty minutes of intake of non-steroidal anti-inflammatory drugs (NSAIDs) for dysmenorrhea. We found bilateral nasal polyps on examination of her nostrils and two previous episodes of similar reactions to NSAIDs. There is a need for increased awareness about this condition among healthcare givers managing patients with bronchial asthma as several cases may be missed in hospital settings. Samter’s triad requires detailed drug history of sensitivity to NSAIDs with accompanying naso-ocular manifestations in all asthmatic patients.

Samter’s triad aspirin-exacerbated respiratory disease bronchial asthma nasal polyp.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.